OR WAIT null SECS
September 03, 2023
Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.
Modular facilities allow for a certain amount of flexibility and reconfiguration options.
A structured cleaning procedure is essential to ensure the effective cleaning of equipment.
September 02, 2023
The ACT EU initiative aims to develop the European Union further as a competitive centre for innovative clinical research.
There are many promising trials in the pipeline that may bring big news for major therapeutic areas.
Audits and inspections both assure that requirements have been fulfilled and whether documented proof is available, says Siegfried Schmitt, vice president, Technical at Parexel.
August 31, 2023
The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation.
Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) is approved as a first-line treatment for anemia in adults with lower-risk myelodysplastic syndromes.
The updated vaccine will be ready to ship following a positive European Commission review.
August 30, 2023
This is the first biosimilar to Tysabri, an injection for adults with multiple sclerosis.